338:HKEXSinopec Shanghai Petrochemical Co. Ltd. Class H Analysis
Data as of 2026-03-14 - not real-time
₩28,650.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Y‑Biologics is trading near its recent resistance level with the 20‑day SMA sitting above the 50‑day SMA, a bullish crossover that aligns with a positive MACD histogram and an RSI comfortably above 50, suggesting short‑term upward momentum.
However, the fundamentals are markedly weak: revenue has collapsed, operating and profit margins are deeply negative, debt-to-equity is extremely high, and the DCF‑derived fair value is less than half the current market price, indicating a substantial overvaluation. The combination of a decreasing volume trend, high 30‑day volatility, and a lack of dividend further underscores the precariousness of the rally.
However, the fundamentals are markedly weak: revenue has collapsed, operating and profit margins are deeply negative, debt-to-equity is extremely high, and the DCF‑derived fair value is less than half the current market price, indicating a substantial overvaluation. The combination of a decreasing volume trend, high 30‑day volatility, and a lack of dividend further underscores the precariousness of the rally.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Current price well above DCF fair value
- Negative earnings and cash flow
- Decreasing volume despite bullish technicals
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential upside if pipeline milestones are achieved
- Persistently high debt and weak profitability
- Volatile price action with mixed technical signals
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Biotech sector upside from successful drug approvals
- Long‑term cash reserves could fund R&D
- Current valuation may eventually correct if clinical data improves
Key Metrics & Analysis
Financial Health
Revenue Growth-72.50%
Profit Margin-241.85%
ROE-49.24%
ROA-14.21%
Debt/Equity139.03
Op. Cash Flow₩-5256522752
Free Cash Flow₩12.5B
Industry P/E26.2
Technical Analysis
TrendBullish
RSI61.1
Support₩20,050.00
Resistance₩28,750.00
MA 20₩24,982.50
MA 50₩24,584.00
MA 200₩17,661.05
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value₩12,885.87
GradeOvervalued
TypeValue
Risk Assessment
Beta0.48
Volatility101.37%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.